QualityStocksNewsBreaks Archives - Page 1366 of 1372

WednesdayJul 12, 2017 9:55 am

QualityStocksNewsBreaks – CD International Enterprises, Inc. (CDII) Announces Contract to Purchase 120,000 Tons of Copper Concentrate

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced that it has entered into a purchase contract to purchase 120,000 tons of copper concentrate (30% Cu) over a 12-month period from a Chile-based company. The initial contract values approximately $260 million based on the current copper future price on the London Metal Exchange. “We are very excited to enter this purchase contract, as we continue to source mineral commodity for our Chinese clients,” Dr. James Wang, chairman and CEO of CD International, stated in the…

TuesdayJul 11, 2017 8:55 am

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Eyes Expansion in Major US Markets with Entry into National Deployment Agreement

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced its agreement with a national deployment partner to manage the deployment, implementation and scaling of the ORHub Surgical Resource Management Platform in hospitals that serve 10 major U.S. metropolitan markets. “We are excited to partner with one of the most elite health care consulting firms in the country,” Colt Melby, CEO of ORHub, stated in the news release. “This partnership gives ORHub immediate reach into a national delivery infrastructure, allowing us to focus on advancing our software and analytics platform while helping more hospitals and surgeons make better real-time,…

MondayJul 10, 2017 11:26 am

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Software Highlighted in Microsoft Publication

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced the availability of a Microsoft publication highlighting the company’s surgical resource management (SRM) solution, which is in use at the Hoag Orthopedic Institute in Irvine, California. The case study, titled “Orthopedic hospital tests cloud-based cure for symptoms of rising healthcare costs,” discusses Hoag’s experience using ORHub’s software as an actionable resource analytics tool for its spinal surgeries. Notably, the cloud-based software, which is accessed directly in the operating room, supports improved teamwork, automates manual processes and streamlines resource allocation in the face of rising health care costs. “We've seen from…

MondayJul 10, 2017 9:45 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Bitcoin Payment Functionality for ChineseHempOil.com Inc. Subsidiary

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned subsidiary, ChineseHempOil.com Inc., will officially accept bitcoin payments. Per the update, consumers who buy hemp-based products, foods and beverages from the ChineseHempOil.com site will have the option to pay with bitcoin, in addition to more common payment methods such as debit cards and PayPal. “I am delighted to announce the addition of Bitcoin payment to the ChineseHempOil.com site,” Warren Wang, founder and CEO of CIIX, stated in the news release. “By providing advanced payment technology such as Bitcoin, consumers will benefit from cost savings, increased privacy and…

MondayJul 10, 2017 9:13 am

QualityStocksNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Enters Research and Development Collaboration with ATERA SAS

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company specializing in the development of advanced human tissue models. Under the terms of the agreement, ATERA will develop 3D human skin models of Epidermolysis Bullosa (EB) to be used in the evaluation of INM-750, InMed’s proprietary topical cannabinoid product candidate targeted as a therapy in EB and other potential dermatological and wound-healing applications. “INM-750 has demonstrated significant potential in pre-clinical models to address symptomatic improvement of EB including…

MondayJul 10, 2017 8:49 am

QualityStocksNewsBreaks – ProBility Media Corp. (PBYA) Retains PCG Advisory Group

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced that it has retained PCG Advisory Group, a leading integrated communications firm, to serve as an advisor for its investor relations and social media communications strategies. “In the eight months since becoming a publicly traded company, ProBility has executed on its business plan and achieved record sales and growth,” Evan Levine, chairman and CEO of ProBility, stated in the news release. “In the first half of 2017, we have already closed and successfully integrated three acquisitions and have several additional opportunities in the pipeline. Our team is now initiating…

FridayJun 30, 2017 2:16 pm

QualityStocksNewsBreaks – Player’s Network, Inc. (PNTV) Announces Availability of Green Leaf Farms Rosin Products at Las Vegas Dispensary

Player’s Network, Inc. (OTCQB: PNTV) today announced the availability of its Green Leaf Farms rosin products at the Pisos Dispensary, located just a few miles from the Las Vegas Strip. “This day has been a long time coming. It marks both the end of prohibition and the true beginning of mass distribution for Green Leaf Farms products,” Mark Bradley, CEO of Player’s Network, stated in the news release. “Our products are now available at the Pisos Dispensary in Las Vegas, as well as in top notch dispensaries in Henderson. We are aggressively moving on the opportunities provided by this growing…

FridayJun 30, 2017 12:49 pm

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Driving Health Care Cost Reduction of Up to 40% with Value-Based Software

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) was featured in a recent case study evaluating the value of its innovative platform at the Hoag Orthopedic Institute (HOI). Among the highlights from the study, researchers found that, by leveraging Microsoft Azure intelligence and analytics, ORHub is capable of helping medical providers achieve cost efficiencies of as much as 40 percent while simultaneously driving closure of reimbursement gaps. The significance of these potential savings is reinforced when studying current health care expenditures in the U.S., which exceed $3 trillion annually and account for roughly 17 percent of GDP. ORHub’s research indicates…

ThursdayJun 29, 2017 3:30 pm

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Enters High-Volume Manufacturing Agreement with Premier Biomedical (BIEI)

Premier Biomedical, Inc. (OTCQB: BIEI), a research-based company focused on the discovery and development of medical treatments for a wide range of diseases, this morning announced that it has reached an agreement with specialized holding company SinglePoint, Inc. (OTC: SING) to manufacture Premier’s new-design CBD Hemp Oil Patch in high volume. “We have been working very hard on making acquisitions and inside sales to boost revenues,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “This new business will contribute significantly to our revenue goals.” Per the update, Premier’s CBD Hemp Oil Skin Patch is expected to be the…

ThursdayJun 29, 2017 12:41 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals, Inc. (IMLFF) Poised to Benefit from Scientific Reviews Concerning Medical Efficacy of Cannabinoids

An increasing volume of research demonstrates the medical efficacy of cannabinoids to treat a variety of medical concerns. InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems, currently has two potential blockbuster therapies in development that are undergoing scientific review. “With areas of research in dermatology, ocular indications, pain and inflammation, central nervous system disorders, and respiratory and metabolic diseases, InMed’s current pipeline is targeting unmet medical conditions utilizing disease-specific formulations. InMed’s INM-750 may become the first therapy to modulate disease activity…

Site Search

Company Search

Category: QualityStocksNewsBreaks